$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Vaginal delivery of drugs 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-006/06
  • A61F-013/02
  • A61F-006/14
출원번호 US-0324624 (2002-12-19)
등록번호 US-8226972 (2012-07-24)
발명자 / 주소
  • DiPiano, Gerianne Tringali
  • Ziemniak, John A.
  • Janicki, Thomas
출원인 / 주소
  • FemmePharma Holding Company, Inc.
대리인 / 주소
    Pabst Patent Group LLP
인용정보 피인용 횟수 : 0  인용 특허 : 65

초록 ▼

Drug delivery compositions which are suitable for vaginal administration for the treatment of diseases and disorders in the urogenital tract are described. The compositions may be in the form of a tablet, liquid suspension or dispersion, dried powder, topical ointment, cream, foam, suppository, or a

대표청구항 ▼

1. A method for treating urinary incontinence comprising administering into the vagina a dosage of a drug formulation wherein the active agent consists of between about 1 mg and about 20 ofa drug selected from the group consisting of tolterodine tartrate, propantheline, and oxybutynin hydrochloride,

이 특허에 인용된 특허 (65) 인용/피인용 타임라인 분석

  1. Beck Lee R. (Birmingham AL) Flowers ; Jr. Charles F. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Tanquary Albert C. (Birmingham AL), Active/passive immunization of the internal female reproductive organs.
    상세보기
  2. Greidanus Pieter J. (Bergschenhoek NLX) Feijen Jan (Hengelo NLX) Eenink Marinus J. D. (Enschede NLX) Rieke Johannes C. (Delft NLX) Olijslager Jan (Delft NLX) Albers Jan H. M. (Rijswijk NLX), Biodegradable polymer substrates loaded with active substance suitable for the controlled release of the active substanc.
    상세보기
  3. Castillo Ernesto J. (St. Peters MO) Eigenberg Kenneth E. (St. Louis MO) Patel Kanaiyalal R. (Coeur MO) Sabacky Milton J. (Ballwin MO), Coated veterinary implants.
    상세보기
  4. Castillo Ernesto J. (St. Peters MO) Eigenberg Kenneth E. (St. Louis MO) Patel Kanaiyalal R. (Creve MO) Sabacky Milton J. (Ballwin MO), Coated veterinary implants.
    상세보기
  5. Hutsell Thomas C. (North Oaks MN), Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents.
    상세보기
  6. Lange Wolfgang (Obernburg DEX) Boer G. J. (Muidenberg NLX), Composite body for long-term delivery of effective substances.
    상세보기
  7. Deaver, Daniel R.; Edwards, David A., Compositions and methods for enhancing receptor-mediated cellular internalization.
    상세보기
  8. Sanders, Steven W.; Ebert, Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    상세보기
  9. Ekwuribe Nnochiri N. (Southfield MI), Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and m.
    상세보기
  10. Ekwuribe Nnochiri N. (Southfield MI), Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and m.
    상세보기
  11. Crowley ; Jr. William F. (Newtonville MA), Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for u.
    상세보기
  12. Crowley ; Jr. William F. (Newtonville MA), Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for u.
    상세보기
  13. Park Tae G. (Cambridge MA) Cohen Smadar (Petach-Tickva MA ILX) Langer Robert S. (Newton MA), Controlled drug delivery using polymer/pluronic blends.
    상세보기
  14. Khan M. Amin (Burlington MA) Bernstein Howard (Cambridge MA), Controlled release ACTH containing microspheres.
    상세보기
  15. Price Ronald R. (Stevensville MD) Gaber Bruce P. (Bethesda MD), Controlled release of active agents using inorganic tubules.
    상세보기
  16. Modi Pankaj (1298 Main St. W. ; Apt. 608 Hamilton ; Ontario CAX L8S 1J4), Controlled release of drugs or hormones in biodegradable polymer microspheres.
    상세보기
  17. Labrie Fernand (Quebec CAX) Lepage Martin (Quebec CAX), Controlled release systems and low dose androgens.
    상세보기
  18. Maniar Manoj (Baltimore MD) Domb Abraham J. (Baltimore MD), Controlled released microparticulate delivery system for proteins.
    상세보기
  19. Znaiden Alexander P. (Trumbull CT) Cheney Michael C. (Fairfield CT) Slavtcheff Craig S. (Cheshire CT) Cho Suk H. (Bogota NJ), Cosmetic compositions for reducing or preventing signs of cellulite.
    상세보기
  20. Schmidt Alfred,DEX ; Wieland Heinrich,DEX, Cosmetic or cosmetic product for firming and smoothing the skin, in particular in the case of cellulite.
    상세보기
  21. Schmidt Alfred,DEX ; Wieland Heinrich,DEX, Cosmetic or cosmetic product for firming and soothing the skin in particular in the case of cellulite.
    상세보기
  22. Anu Mahashabde ; Martha Francine Kay ; Donald F. Koelmel, Device and method for treating urinary incontinence in females.
    상세보기
  23. Vorys Nichols (336 S. Columbia Ave. Columbus OH 43209), Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system.
    상세보기
  24. Vorys Nichols (336 S. Columbia Ave. Columbus OH 43209), Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system.
    상세보기
  25. Kong William C. ; Yeung Raymond, Herbal cellulite treatments.
    상세보기
  26. Oppenheim ; Richard Charles ; Marty ; Jennifer Joy ; Speiser ; Peter, Injectable compositions, nanoparticles useful therein, and process of manufacturing same.
    상세보기
  27. Van Os Willem A. A. (L\Espranza ; 17 Rue Bosio ; 98000 MCX), Intrauterine contraceptive device.
    상세보기
  28. Pike Malcolm C. (Long Beach CA) Spicer Darcy V. (Pasadena CA), Method and formulations for use in treating benign gynecological disorders.
    상세보기
  29. Nyce Jonathan W., Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone.
    상세보기
  30. Dorogi Peter Ladislaus ; McCook John Patrick, Method for reducing human body cellulite by treatment with pulsed electromagnetic energy.
    상세보기
  31. Igarashi Masao (357-4 ; Hiyoshi-cho H-chome Maebashi-shi ; Gunma JPX), Method for treating endometriosis with topical preparations containing danazol.
    상세보기
  32. Cheesman ; Dean W., Method of reducing mammalian fertility and drugs therefor.
    상세보기
  33. D\Angelo Joseph P. (Miami FL) Schur Henry (Miami FL), Method of transdermally administering high molecular weight drugs with a polymer skin enhancer.
    상세보기
  34. Labrie Fernand (Quebec CAX), Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds.
    상세보기
  35. Jaffe Howard (Gaithersburg MD), Microencapsulation process.
    상세보기
  36. Guittard George V. (Cupertino CA) Deters Joseph C. (Mountain View CA) Theeuwes Felix (Los Altos CA) Cortese Richard (San Jose CA), Osmotic system with instant drug availability.
    상세보기
  37. Angeles Uribe Juan (Mexico MXX) Garza Flores Josue (Mexico MXX), Parenteral dosage form.
    상세보기
  38. Mauvais-Jarvis Pierre (12 ; Parc de Bearn F-92210 Saint Cloud FRX) Kuttenn Frdrique (6 ; Avenue des Gobelins F-75008 Paris FRX), Percutaneous administration of tamoxifen.
    상세보기
  39. Baker Richard W. (Palo Alto CA), Periodontal disease treatment system.
    상세보기
  40. Howard Murad, Pharmaceutical compositions for reducing the appearance of cellulite.
    상세보기
  41. Santus Giancarlo (Milan ITX) Bottoni Giuseppe (Bergamo ITX) Sala Giovanni (Verona ITX), Pharmaceutical controlled-release composition with bioadhesive properties.
    상세보기
  42. Ragavan Vanaja V. ; DiPiano Gerrianne M., Pharmaceutical preparations and methods for their administration.
    상세보기
  43. Ragavan, Vanaja V.; DiPiano, Gerianne M., Pharmaceutical preparations and methods for their regional administration.
    상세보기
  44. Vanaja V. Ragavan ; Gerianne M. DiPiano, Pharmaceutical preparations and methods for their regional administration.
    상세보기
  45. Mathiowitz Edith (Brookline MA) Langer Robert S. (Somerville MA), Preparation of multiwall polymeric microcapsules.
    상세보기
  46. Cohen Jonathan M. (Elmont NY) Siegel Ronald (Arlington Hts. MA) Langer Robert (Somerville MA), Process for making systems for the controlled release of macromolecules.
    상세보기
  47. Bosch H. William (Bryn Mawr PA) Marcera Donna M. (Collegeville PA) Mueller Ronald L. (Downingtown PA) Swanson Jon R. (Macungie PA) Mishra Dinesh S. (Harleysville PA), Process for preparing therapeutic compositions containing nanoparticles.
    상세보기
  48. Moro Luigi (Milan ITX) Fiori Achille (Milan ITX) Natali Alberto (Milan ITX), Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related.
    상세보기
  49. Dong Liang C. (Mountain View CA) Wong Patrick S.-L. (Palo Alto CA) Espinal Steven (Sunnyvale CA), Progesterone replacement therapy.
    상세보기
  50. Champagne Edwin B. (Kettering OH), Radar system for reducing angle tracking errors.
    상세보기
  51. Soudant Etienne (Fresnes FRX) Nadaud Jean-Francois (Paris FRX), Slimming composition based on Ginkgo biloba as an alpha-2-blocker.
    상세보기
  52. Iida Yoshimitsu (Saitama JPX), Slow-release pharmaceutical agent.
    상세보기
  53. Azuma Ichiro (Sapporo JPX) Tokura Seiichi (Sapporo JPX) Nishimura Shinichiro (Sapporo JPX) Seo Hiroshi (Souka JPX), Slow-releasing preparation.
    상세보기
  54. Aaron Tabor, Soy formulations and their use for promoting health.
    상세보기
  55. Calvo Salve Pilar,ESX ; Alonso Fernandez Maria Jose,ESX ; Remunan Lopez Carmen,ESX ; Vila Jato Jose Luis,ESX, Stabilization of colloidal systems through the formation of lipid-polyssacharide complexes.
    상세보기
  56. Liversidge Gary G. (West Chester PA) Conzentino ; Jr. Philip (West Chester PA) Cundy Kenneth C. (Pottstown PA) Sarpotdar Pramod P. (Malvern PA), Surface modified NSAID nanoparticles.
    상세보기
  57. Liversidge Gary G. (West Chester PA) Cundy Kenneth C. (Pottstown PA) Bishop John F. (Rochester NY) Czekai David A. (Honeoye Falls NY), Surface modified drug nanoparticles.
    상세보기
  58. Krenning Eric P. (Rotterdam NLX) Hennemann Georg (Rotterdam NLX), Sustained release thyroactive composition.
    상세보기
  59. Folkman Moses J. (Brookline MA) Langer ; Jr. Robert S. (Allston MA), Systems for the controlled release of macromolecules.
    상세보기
  60. Han Jui (1 Xian Nong Tan St. Beijing CNX) Sun Yan (Cancer Institute & Hospital ; 1-4-6 Beijing CNX), Topical application of glyciphosphoramide.
    상세보기
  61. Orup Jacobsen, Lene; Kreilgard, Bo; Hoeck, Ulla; Kristensen, Helle, Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder.
    상세보기
  62. Greenway ; III Frank L. (4560 Admiralty Way ; Suite 301 Marina Del Rey CA 90291) Bray George A. (234 S. Figueroa ; #1035 Los Angeles CA 90012), Treatment for selective reduction of regional fat deposits.
    상세보기
  63. Garfield Robert E. ; Chwalisz Kristof,DEX, Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combinati.
    상세보기
  64. Oden Per (Motorbtsvagen 38 S-902 91 Tafte SEX), Use of gibberellins for the treatment of prostatitis.
    상세보기
  65. Wong Patrick S. (Kowloon HKX), Vaginal drug delivery system made from polymer.
    상세보기

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로